改良标准型BEACOPP方案治疗进展期霍奇金淋巴瘤患者的护理
摘要
ABVD方案（多柔比星＋博来霉素＋长春新碱＋氮烯眯胺）是公认的治疗进展期霍奇金淋巴瘤（Hodgkin＇s lymphoma，HL）的一线化疗方案，70％-80％的患者治疗后可获得长期缓解，但仍有30％。40％的患者发生疾病进展和复发川。国际上将BEACOPP（博来霉素＋依托泊苷＋多柔比星＋环磷酰胺＋长春新碱＋甲基苄肼＋泼尼松）方案作为治疗HL的一线化疗方案之一，考虑到人种差异，我科于2006年3月至2008年9月采用改良标准型BEACOPP方案治疗HL患者22例，现报道如下。
出处
《中国实用护理杂志》
北大核心
2011年第2期50-51,共2页
Chinese Journal of Practical Nursing
参考文献4
-
1林宁晶,张运涛,郑文,王小沛,宋玉琴,涂梅峰,平凌燕,应志涛,朱军.改良标准型BEACOPP方案治疗进展期霍奇金淋巴瘤的疗效和安全性[J].肿瘤,2010,30(1):42-47. 被引量：1
-
2马丽辉 张金梅.COABPP方案治疗淋巴瘤引起肺间质纤维化1例[J].山西临床医学,1999,8(1):60-60.
-
3王兴国 任小平 张庆民.甲基苄肼引起高热反应及皮疹1例[J].肿瘤,1996,16(3):394-394.
-
4Howell SJ,Shalet SM.Spermatogenesis after cancer treatment damage and recovery.Journal of the National Cancer Institute Monographs,2005,34:112-117.
二级参考文献11
-
1DIEHL V, FRANKLIN J, PFREUNDSCHUH M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin ' s disease [ J ]. N Engl J Med, 2003,348 ( 24 ) :2386-2395.
-
2ANDREAS E, FRANKLIN J, DIEHL V. Long-term follow-up of BEACOPP escalated chemotherapy in patients with advanced-stage Hodgkin lymphoma on behalf of the German Hodgkin Study Group [ J ]. Blood, 2007, 110 ( 11 ) : Abstract 211.
-
3HASENCLEVER D, DIEHL V. A prognostic score for advanced Hodgkin' s disease-J]. N Engl J Med, 1998, 339(21 ):1506- 1514.
-
4CHESON B D, PFISTNER B, JUWEID M E, et al. Revised response criteria for malignant lyrnphoma[ J]. J Clin Oncol, 2007, 25(5) :579-586.
-
5EVENS A M, HUTCI-HNGS M, DIEHL V. Treatment of Hodgkin' s lymphoma: the past, present, and future [ J ]. Nat Clin Pract Oncol, 2008,5 ( 9 ) :543-556.
-
6DIEHL V, ENGERT A. Will it be another 20 years before Hodg!dn lymphoma patients benefit from BEACOPP therapy? [ J ]. Nat Clin Pract Oncol, 2006,3 ( 5 ) :227.
-
7ECONOMOPOULOS T, FOUNTZILAS G, DIMOPOULOS M A, et al. Treatment of intermediate and advanced stage Hodgkin' s disease with modified baseline BEACOPP regimen: a Hellenic Cooperative Oncology Group Study[Jl. EurJHaematol, 2003,71 (4) :257-262.
-
8NIITSU N, OKAMOTO M, TOMITA N, et al. Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin' s lymphoma [ J ]. Leuk Lymphoma, 2006, 47(9) : 1908-1914.
-
9BREDENFELD H, FRANKLIN J, NOGOVA L, et al. Severe pulmonary toxicity in patients with advanced-stage Hodgkin' s disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin' s Lymphoma Study Group [ J ]. J Clin Oncol, 2004,22 ( 12 ) :2424-2429.
-
10BALLOVAI V, RUFFER J U, HAVERKAMP H, et al. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin' s disease comparing BEACOPP baseline and COPP-ABVD (study HD9 elderly) [ J]. Ann Oncol, 2005,16( 1 ) : 124-131.
-
1张克信,韩振海,郭光瑷,严汝萍,杜心佳,杜现华.黄色瘤一例报告[J].齐鲁肿瘤杂志,1996,3(3):242-242. 被引量：1
-
2林宁晶,张运涛,郑文,王小沛,宋玉琴,涂梅峰,平凌燕,应志涛,朱军.改良标准型BEACOPP方案治疗进展期霍奇金淋巴瘤的疗效和安全性[J].肿瘤,2010,30(1):42-47. 被引量：1
-
3郑光海,林芃,张祥福,魏孝钰.COPP方案治疗小儿早期恶性淋巴瘤[J].福建医科大学学报,1994,30(4):393-393.
-
4人种的差异会影响结肠直肠癌的预后[J].中华医学信息导报,2002,17(11):10-10.
-
5张俊平,魏大年,赛克,牟永告,张湘衡,王涤宇,陈忠平.替莫唑胺治疗国人恶性脑胶质瘤:31例临床疗效分析[J].中国新药与临床杂志,2007,26(7):534-538. 被引量：5
-
6黄云生.子宫肉瘤临床病理与预后[J].蚌埠医学院学报,1999,24(5):345-346.
-
7陈明强,林祥松,陈娜.鼻腔非何杰金淋巴瘤的治疗[J].医药论坛杂志,1994,5(4):1-2.
-
8杨瑞芬,周明宣,李烽,吴颖.以ABVD方案治疗复发/难治性非霍奇金淋巴瘤[J].肿瘤研究与临床,2000,12(5):322-323.
-
9刘淑真,宋晓红,张万堂,段湘云,王黎,杨蔚萱,蒋英华.用COPP方案治疗非何杰金氏恶性淋巴瘤的疗效观察[J].河南肿瘤学杂志,1992,5(3):52-53.
-
10童浩,贾霖,韩建军,高飞,王允,况小红.霍奇金淋巴瘤序贯化疗临床研究[J].西部医学,2008,20(5):1043-1044.
